113 related articles for article (PubMed ID: 35532802)
1. [Endovascular interventions for peripheral arterial disease].
Steiner S; Schmidt A
Inn Med (Heidelb); 2022 Jun; 63(6):584-590. PubMed ID: 35532802
[TBL] [Abstract][Full Text] [Related]
2. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
3. Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the "SirPAD" randomized controlled trial.
Barco S; Sebastian T; Voci D; Engelberger RP; Grigorean A; Holy E; Leeger C; Münger M; Périard D; Probst E; Spescha R; Held U; Kucher N
Trials; 2022 Apr; 23(1):334. PubMed ID: 35449070
[TBL] [Abstract][Full Text] [Related]
4. Endovascular intervention for peripheral artery disease.
Thukkani AK; Kinlay S
Circ Res; 2015 Apr; 116(9):1599-613. PubMed ID: 25908731
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
6. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
7. [Interventional angiology : Endovascular treatment of chronic and acute limb ischemia].
Steiner S; Schmidt A; Scheinert D
Internist (Berl); 2019 Feb; 60(2):149-160. PubMed ID: 30683968
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
[No Abstract] [Full Text] [Related]
9. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
10. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.
Aru RG; Tyagi SC
Semin Vasc Surg; 2022 Jun; 35(2):180-189. PubMed ID: 35672108
[TBL] [Abstract][Full Text] [Related]
11. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
12. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
[TBL] [Abstract][Full Text] [Related]
14. Rotational Atherectomy Plus Drug-Coated Balloon Angioplasty for the Treatment of Total In-Stent Occlusions in Iliac and Infrainguinal Arteries.
Milnerowicz A; Milnerowicz A; Kuliczkowski W; Protasiewicz M
J Endovasc Ther; 2019 Jun; 26(3):316-321. PubMed ID: 30907258
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
[TBL] [Abstract][Full Text] [Related]
17. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
18. How to compare results from open with endovascular procedures?
Bosiers M; Deloose K; Callaert J; Peeters P; Wauters J
J Cardiovasc Surg (Torino); 2020 Apr; 61(2):196-199. PubMed ID: 29745216
[TBL] [Abstract][Full Text] [Related]
19. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
Engin AY; Saydam O
Vascular; 2021 Oct; 29(5):682-692. PubMed ID: 33167805
[TBL] [Abstract][Full Text] [Related]
20. Specialty Balloons for Vessel Preparation During Infrainguinal Endovascular Revascularization Procedures: A Review of Literature.
Giannopoulos S; Volteas P; Virvilis D
Vasc Endovascular Surg; 2023 Aug; 57(6):599-606. PubMed ID: 36745906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
